Concepedia

Novel Short-Acting A2A Adenosine Receptor Agonists for Coronary Vasodilation: Inverse Relationship between Affinity and Duration of Action of A2A Agonists

Zhenhai Gao, Zhihe Li, Stephen P. Baker, Robert D. Lasley, Stephanie Meyer, Elfatih Elzein, Venkata P. Palle, Jeff Zablocki, Brent Blackburn, Luiz Belardinelli

Journal of Pharmacology and Experimental Therapeutics · 2001 · 123 citations · 21 references

DOI

Concepts

References

21

The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A<sub>2a</sub>selective adenosine receptor antagonist

Simon M. Poucher, J R Keddie, Parminder Singh et al. · British Journal of Pharmacology · 1995 · 364 citations · Full text

, , +8

CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.

A. Hutchison, Randy L. Webb, H H Oei et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 245 citations · Full text

, , +8

Pharmacological analysis of drug-receptor interaction

Manfred Kietzmann · Toxicon · 1994 · 225 citations

, , +14

A<sub>2A</sub>-Adenosine Receptor Reserve for Coronary Vasodilation

John C. Shryock, Stephen Snowdy, Pier Giovanni Baraldi et al. · Circulation · 1998 · 190 citations

, , +16

The A2A Adenosine Receptor Mediates Coronary Vasodilation

Luiz Belardinelli, John C. Shryock, Stephen Snowdy et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 181 citations

, , +10